DNA gyrase inhibitors (GSK)

N/A

Report date: 2025/03/19 11:37:00
NME

Base Information

Drug NameDNA gyrase inhibitors (GSK)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionBacterial DNA gyrase inhibitors
TargetsBacterial DNA gyrase
Therapy Area/IndicationsStaphylococcal InfectionsGram-Positive Bacterial InfectionsEscherichia coli Infections +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsStaphylococcal InfectionsGram-Positive Bacterial InfectionsEscherichia coli Infections +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A